pharmaphorum | News & views on pharma and biotech’s evolving …
WEBpharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
News | Timely industry updates for pharma and biotech leaders
WEB1 day ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of ...
WEB4 days ago · Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category. Mounjaro, manufactured by ...
Designing HCP engagement for the next normal | pharmaphorum
WEB2 days ago · Life sciences companies’ engagement with HCPs has changed significantly in the past 12 months, as the COVID-19 pandemic struck. Restrictions to in-person face-to-face interactions have resulted ...
Views & Analysis | Perspectives on pharma industry issues
WEB2 days ago · Diverse and engaging perspectives on pharma developments and debates from pharmaphorum editors, industry insiders, and contributing experts.
Increasing sustainability in pharma requires an industry-wide effort
WEB4 days ago · After FDA no, MSD/Daiichi post new data with lung cancer ADC. MSD and Daiichi Sankyo's patritumab deruxtecan hit its main objective in a phase 3 lung cancer study that reinforces its potential as ...
AI addresses brain health - pharmaphorum
WEBResearch and Development Disruption 2020 | AI addresses brain health. Neurodegenerative diseases, such as Parkinson’s, for example, can currently only be detected by the presence of substantial and bothersome motor difficulties – but by the time a patient is exhibiting such symptoms, in some …
Pharma | pharmaphorum
WEBAdvanz Pharma's bid to keep Ocaliva on EU market fails. The European Commission has followed the advice of its human medicines committee and revoked the conditional marketing authorisation for ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
WEBFeb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Digital | Exploring pharma's evolving digital future - pharmaphorum
WEBStay up to date on digital health, digital therapeutics, AI use cases, and technological innovation on pharmaphorum's dedicated digital channel.